These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3111140)

  • 21. Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma.
    Kanda Y; Arai C; Chizuka A; Suguro M; Hamaki T; Yamamoto R; Yamauchi Y; Matsuyama T; Takezako N; Shirai Y; Miwa A; Iwasaki K; Nasu M; Togawa A
    Leuk Lymphoma; 2000 Apr; 37(3-4):445-9. PubMed ID: 10752998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.
    van der Griend R; Verdonck LF; Petersen EJ; Veenhuizen P; Bloem AC; Lokhorst HM
    Bone Marrow Transplant; 1999 Jan; 23(2):195-7. PubMed ID: 10197809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
    Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
    Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
    Stem Cells; 1995 Aug; 13 Suppl 2():122-5. PubMed ID: 8520500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
    Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno NT; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R
    Bone Marrow Transplant; 2002 Sep; 30(6):367-73. PubMed ID: 12235521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
    Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
    Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in treatment of multiple myeloma].
    Gola A
    Acta Haematol Pol; 1992; 23(4):229-35. PubMed ID: 1293903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect?
    Forsyth C; Nelson M; Popp H; Snowdon L; Gibson J; Joshua D
    Bone Marrow Transplant; 1996 Mar; 17(3):457-9. PubMed ID: 8704707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma: a case of a cure?
    Robert JL; Tubiana N; Lejeune C; Carcassonne Y
    Nouv Rev Fr Hematol (1978); 1989; 31(1):35-7. PubMed ID: 2644619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study.
    Gahrton G; Tura S; Ljungman P; Belanger B; Brandt L; Cavo M; Chapuis B; De Laurenzi A; de Witte T; Facon T
    Bone Marrow Transplant; 1991; 7 Suppl 2():32. PubMed ID: 1878706
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma.
    Byrne JL; Carter GI; Bienz N; Haynes AP; Russell NH
    Bone Marrow Transplant; 1998 Oct; 22(7):639-43. PubMed ID: 9818690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who benefits from high-dose therapy for multiple myeloma?
    Anderson KC
    J Clin Oncol; 1995 Jun; 13(6):1291-6. PubMed ID: 7751873
    [No Abstract]   [Full Text] [Related]  

  • 37. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
    Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
    Bone Marrow Transplant; 1999 Oct; 24(7):741-5. PubMed ID: 10516677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation for multiple myeloma.
    Tura S; Cavo M; Rosti G; Bandini G; Gobbi M; Grimaldi M; Miggiano MC; Albertazzi L; Bonelli MA
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():106-8. PubMed ID: 2697418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report.
    Rondelli D; Bandini G; Cavo M; Re F; Motta M; Senese B; Leopardi G; Stanzani M; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(6):685-7. PubMed ID: 10490737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
    Kröger N; Perez-Simon JA; Myint H; Klingemann H; Shimoni A; Nagler A; Martino R; Alegre A; Tomas JF; Schwerdtfeger R; Kiehl M; Fauser A; Sayer HG; Leon A; Beyer J; Zabelina T; Ayuk F; San Miguel JF; Brand R; Zander AR
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):698-708. PubMed ID: 15389436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.